Spleen Tyrosine Kinase (Syk)
Spleen Tyrosine Kinase (Syk)(脾酪氨酸激酶 (Syk))
Syk is a family of non-receptor cytoplasmic tyrosine kinases that plays a role in transmitting signals from a variety of cell surface receptors including CD74, Fc Receptor, and integrins.
Spleen Tyrosine Kinase (Syk) 相关产品(33)
- GC12136BAY 61-3606 dihydrochlorideCAS: 648903-57-5纯度: >98.00%
BAY 61-3606 dihydrochloride 是一种可口服的、ATP 竞争性、可逆和高选择性的 Syk 抑制剂,Ki 为 7.5 nM,IC50 为 10 nM。
- GC10499PRT062607 HydrochlorideCAS: 1370261-97-4纯度: >98.00%
PRT062607 Hydrochloride (P505-15 Hydrochloride) 是一种高度特异性和有效的纯化 Syk 抑制剂 (IC50 1-2 nM)。
- GC15709R788 disodium hexahydrateCAS: 914295-16-2纯度: >98.00%
Fostamatinib (R788) 二钠六水合物是活性化合物 R406 的口服前药。
- GC19344TAK-659 hydrochlorideCAS: 1952251-28-3纯度: >99.50%
TAK-659 hydrochloride 是一种高效、选择性、可逆和口服的脾酪氨酸激酶 (SYK) 和 fms 相关酪氨酸激酶 3 (FLT3) 双重抑制剂,对 SYK 和 FLT3 的 IC50 分别为 3.2 nM 和 4.6 nM。 TAK-659 hydrochloride 在肿瘤细胞中诱导细胞死亡,但在非肿瘤细胞中不诱导细胞死亡,并具有治疗慢性淋巴细胞白血病 (CLL) 的潜力。
- GC25787PRT-060318 2HClCAS: 1194961-19-7(freebase)
PRT-060318 (PRT318) is a novel selective inhibitor of the Syk tyrosine kinase with an IC50 of 4 nM, as an approach to HIT treatment.
- GC33041Gusacitinib (ASN-002)CAS: 1425381-60-7纯度: >99.00%
A dual inhibitor of JAKs and Syk family kinases
- GC44978Syk Inhibitor IICAS: 726695-51-8纯度: >98.00%
A selective blocker of spleen tyrosine kinase activity
- GC62456SRX3207CAS: 2254693-15-5纯度: >98.50%
SRX3207 is an orally active dual inhibitor of Syk-PI3K with IC50 of 39.9 nM, 31200 nM, 3070 nM, 3070 nM, 244 nM, 388 nM, 9790 nM for Syk, Zap70, BRD41, BRD42, PI3K alpha, PI3K delta, PI3K gamma, respectively. SRX3207 blocks tumor immunosuppression and increases anti-tumor immunity.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10048 | MNS | 1485-00-3 | - | |
An inhibitor of Src, Syk, and platelet aggregation | ||||
| GC11811 | R788 disodium | 1025687-58-4 | >98.00% | |
A prodrug of a Syk inhibitor | ||||
| GC12136 | BAY 61-3606 dihydrochloride | 648903-57-5 | >98.00% | |
BAY 61-3606 dihydrochloride 是一种可口服的、ATP 竞争性、可逆和高选择性的 Syk 抑制剂,Ki 为 7.5 nM,IC50 为 10 nM。 | ||||
| GC16389 | BAY 61-3606 | 732983-37-8 | - | |
A Syk inhibitor | ||||
| GC16430 | GS-9973 | 1229208-44-9 | >98.00% | |
A selective spleen tyrosine kinase inhibitor | ||||
| GC16796 | R406 | 841290-81-1 | - | |
R406是一种口服可用的脾酪氨酸激酶(Syk)抑制剂,IC 50 值为41nM,并以K i =30nM竞争性地抑制ATP结合。 | ||||
| GN10503 | Piceatannol | 10083-24-6 | >98.00% | |
Piceatannol(3,3 ',4,5 ' -反式三羟基二苯乙烯)是天然存在的白藜芦醇羟基化类似物。 | ||||
| GC10499 | PRT062607 Hydrochloride | 1370261-97-4 | >98.00% | |
PRT062607 Hydrochloride (P505-15 Hydrochloride) 是一种高度特异性和有效的纯化 Syk 抑制剂 (IC50 1-2 nM)。 | ||||
| GC11209 | Cerdulatinib (PRT062070) | 1198300-79-6 | >99.50% | |
A dual inhibitor of Syk and JAKs | ||||
| GC11321 | PRT-060318 | 1194961-19-7 | >99.50% | |
A potent and selective Syk inhibitor | ||||
| GC15466 | RO9021 | 1446790-62-0 | >98.50% | |
RO9021 是一种具有口服生物利用度的新型 ATP 竞争性 SYK 抑制剂,平均 IC50 为 5.6 nM。 | ||||
| GC15658 | R406(free base) | 841290-80-0 | >99.50% | |
A potent and selective Syk inhibitor | ||||
| GC15709 | R788 disodium hexahydrate | 914295-16-2 | >98.00% | |
Fostamatinib (R788) 二钠六水合物是活性化合物 R406 的口服前药。 | ||||
| GC19344 | TAK-659 hydrochloride | 1952251-28-3 | >99.50% | |
TAK-659 hydrochloride 是一种高效、选择性、可逆和口服的脾酪氨酸激酶 (SYK) 和 fms 相关酪氨酸激酶 3 (FLT3) 双重抑制剂,对 SYK 和 FLT3 的 IC50 分别为 3.2 nM 和 4.6 nM。 TAK-659 hydrochloride 在肿瘤细胞中诱导细胞死亡,但在非肿瘤细胞中不诱导细胞死亡,并具有治疗慢性淋巴细胞白血病 (CLL) 的潜力。 | ||||
| GC25787 | PRT-060318 2HCl | 1194961-19-7(freebase) | - | |
PRT-060318 (PRT318) is a novel selective inhibitor of the Syk tyrosine kinase with an IC50 of 4 nM, as an approach to HIT treatment. | ||||
| GC31819 | PRT062607 (P505-15) | 1370261-96-3 | - | |
A potent, orally bioavailable Syk inhibitor | ||||
| GC33041 | Gusacitinib (ASN-002) | 1425381-60-7 | >99.00% | |
A dual inhibitor of JAKs and Syk family kinases | ||||
| GC33874 | R112 | 575474-82-7 | >99.00% | |
A Syk inhibitor | ||||
| GC36423 | Lanraplenib | 1800046-95-0 | >98.00% | |
A Syk inhibitor | ||||
| GC37723 | TAK-659 | 1312691-33-0 | - | |
TAK-659 is a potent and selective inhibitor of spleen tyrosine kinase (SYK) with an IC50 value of 3.2 nM. It is selective against most other kinases, but potent toward both SYK and FLT3. | ||||
| GC38630 | Lanraplenib succinate | 1800047-00-0 | >98.00% | |
A Syk inhibitor | ||||
| GC44978 | Syk Inhibitor II | 726695-51-8 | >98.00% | |
A selective blocker of spleen tyrosine kinase activity | ||||
| GC61942 | Syk-IN-1 | 1491150-77-6 | >99.00% | |
Syk-IN-1 (compound 4) 是一种有效的 Syk 抑制剂,IC50为 35 nM。 | ||||
| GC62456 | SRX3207 | 2254693-15-5 | >98.50% | |
SRX3207 is an orally active dual inhibitor of Syk-PI3K with IC50 of 39.9 nM, 31200 nM, 3070 nM, 3070 nM, 244 nM, 388 nM, 9790 nM for Syk, Zap70, BRD41, BRD42, PI3K alpha, PI3K delta, PI3K gamma, respectively. SRX3207 blocks tumor immunosuppression and increases anti-tumor immunity. | ||||
